Jose Angel Ruiz-Ortega

Affiliations: 
 
Google:
"Jose Angel Ruiz-Ortega"
Mean distance: 18.32 (cluster 32)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Requejo C, López-de-Ipiña K, Ruiz-Ortega JÁ, et al. (2020) Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson's Disease: Exploring Prodromal Biomarkers. Frontiers in Neuroscience. 14: 590029
Antonazzo M, Botta M, Bengoetxea H, et al. (2019) Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders. International Review of Neurobiology. 146: 229-257
Hernando S, Requejo C, Herran E, et al. (2018) Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation. Neurobiology of Disease
Sagarduy A, Llorente J, Miguelez C, et al. (2016) Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors Experimental Neurology. 277: 35-45
Requejo C, Ruiz-Ortega JA, Bengoetxea H, et al. (2015) Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease-Effects of Nanoencapsulated Neurotrophic Factors Administration. Molecular Neurobiology
Herrán E, Requejo C, Ruiz-Ortega JA, et al. (2014) Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease. International Journal of Nanomedicine. 9: 2677-87
Miguelez C, Morera-Herreras T, Torrecilla M, et al. (2014) Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. Frontiers in Neural Circuits. 8: 21
Azkona G, Sagarduy A, Aristieta A, et al. (2014) Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats. Neuropharmacology. 79: 726-37
Aristieta A, Morera-Herreras T, Ruiz-Ortega JA, et al. (2014) Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration. Psychopharmacology. 231: 1913-24
Fernández De Aránguiz MY, Berraondo MR, Fernández De Aránguiz A, et al. (2014) Gradual development of cross-curricular competencies in the Pharmacy Degree. Methodologies and evaluation tools for the "professional in training" | Desarrollo gradual de las competencias transversales en el Grado en Farmacia. Metodologías y herramientas de evaluación para el "profesional en formación" Ars Pharmaceutica. 55: 19-28
See more...